Before the entry of generics, Jardiance was priced at ₹58–₹60 per tablet for the 10 mg dose and ₹65–₹70 for the 25 mg variant. Now, domestic firms have drastically reduced prices—Mankind Pharma’s ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Glenmark Pharmaceuticals announced that it has launched generic Empagliflozin, a widely recognized SGLT2 inhibitor, in India.

Rajeev Juneja, Vice-Chairman and Managing Director, Mankind Pharma (Image Credits: FE.com) Boehringer Ingelheim’s blockbuster diabetes Drug Empagliflozin is now off-patent in India. On Wednesday ...

Glenmark Pharmaceuticals Ltd. on Wednesday announced that it has launched Empagliflozin, a widely recognized SGLT2 inhibitor, in India. The drug has been introduced under the brand name Glempa ...